| Literature DB >> 33574353 |
Nana Akiyama1,2, Masaru Shimura3, Taro Yamazaki4, Hiroko Harashima4,5, Takuya Fushimi3, Tomoko Tsuruoka6, Tomohiro Ebihara6, Keiko Ichimoto3, Ayako Matsunaga3, Megumi Saito-Tsuruoka5,7, Yukiko Yatsuka8, Yoshihito Kishita8,9, Masakazu Kohda8, Akira Namba5,7,10, Yoshimasa Kamei10, Yasushi Okazaki8, Shinji Kosugi2, Akira Ohtake11,12,13, Kei Murayama14,15,16.
Abstract
Prenatal diagnoses of mitochondrial diseases caused by defects in nuclear DNA (nDNA) or mitochondrial DNA have been reported in several countries except for Japan. The present study aimed to clarify the status of prenatal genetic diagnosis of mitochondrial diseases caused by nDNA defects in Japan. A comprehensive genomic analysis was performed to diagnose more than 400 patients, of which, 13 families (16 cases) had requested prenatal diagnoses. Eight cases diagnosed with wild type homozygous or heterozygous variants same as either of the heterozygous parents continued the pregnancy and delivered healthy babies. Another eight cases were diagnosed with homozygous, compound heterozygous, or hemizygous variants same as the proband. Of these, seven families chose to terminate the pregnancy, while one decided to continue the pregnancy. Neonatal- or infantile-onset mitochondrial diseases show severe phenotypes and lead to lethality. Therefore, such diseases could be candidates for prenatal diagnosis with careful genetic counseling, and prenatal testing could be a viable option for families.Entities:
Year: 2021 PMID: 33574353 DOI: 10.1038/s41598-021-81015-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379